Leadership Team

"Affinity's Leadership Team is poised to deliver real results in real time."

Based in Cleveland, Ohio, Affinity was established in November 2010 by Drs. Julius Korley and Horst von Recum in collaboration with Case Western Reserve University. Recognizing the dynamic and rapidly changing medical and business environments we operate in, our staff is a vital part of Affinity’s accomplishments thus far. They are knowledgeable and extremely committed to Affinity’s continual ingenuity, reliability, and sustainability. Each staff member brings unique qualifications that are integral to Affinity’s continued success.

 

 

Dr. Julius Korley

Dr. Julius Korley is one of Affinity’s founders and the chief executive officer of the company. Prior to co-founding Affinity, Dr. Korley gained valuable experience from being an early employee at Momenta Pharmaceuticals, a startup that matured into a publicly traded company. Because of his experience at Momenta—a once-small startup company that had an initial public offering after only three years—he knows of the insight, commitment and dedication required to see a project from start to maturation.

As employee No. 21, Dr. Korley attended management team meetings and was able to offer input. This experience provided him with valuable insight into the inner workings of a company and the essentials needed for success.

Through this experience—and several others while completing a Ph.D. in biomedical engineering from Cornell University and a translational research position at Case Western Reserve University—Dr. Korley has equipped himself with the requisite tools to take Affinity from a laboratory technology to a product capable of meeting many human healthcare needs.

In addition to running Affinity, Dr. Korley is also the associate director of the Coulter-Case Translational Research Partnership at Case Western Reserve. This position focuses on translational medicine and the commercialization of laboratory technologies that meet unmet human healthcare needs.

Dr. Korley received a B.S. from Clark Atlanta University, a Ph.D. from Cornell University and most recently an M.B.A. from the Weatherhead School of Management at Case Western Reserve University.

> view linkedin profile

> Read less


 

 

Dr. Horst Von Recum

Co-founder of Affinity Therapeutics, Dr. Horst von Recum has more than 20 years of experience within the fields of chemical and biomedical engineering. A graduate of both Rice University (M.Ch.E) and the University of Utah (Ph.D.), Dr. von Recum spent his postdoctoral tenure conducting research at several of the country’s leading institutions, including MIT and Harvard Medical School.

> Read more


 

Dr. Sean Zuckerman

As senior research scientist for Affinity Therapeutics, Dr. Sean Zuckerman helps develop affinity-based drug delivery platforms into stand-alone products, generate in vivo data demonstrating product safety and efficacy, and write grants to obtain non-dilutive funding.

> Read more
 

Dr. Thomas Facklam

Dr. Thomas Facklam has been a business consultant with Affinity since the company’s inception. Dr. Facklam has more than 25 years of experience in all phases of product development, manufacturing, business development and strategic management in the pharmaceutical, biotech, diagnostic, medical device and agri-food industries. Using his broad technology development and commercialization and business experience, he has assisted companies and organizations to develop efficient business and product development strategies.

> Read more
 

 
    ©2013 Affinity Therapeutics, LLC. All Rights Reserved.   Site Development by Webster Marketing Solutions, Ltd. Site Design by jing.